Company profilePharmaceutical#13 of 1,318 in Pakistan5 DRAP alerts

HILTON PHARMA (PVT) LIMITED

Pharmaceutical company · 397 brands · 352 molecules

Ranked #6 of 137 companies in Anti-Infectives

397 registered products 106 pharmaceutical brands 352 distinct molecules 5 DRAP alerts

Company overview

397
registered products
106
pharmaceutical brands
352
distinct molecules
12
therapeutic classes
5
DRAP alerts

HILTON PHARMA (PVT) LIMITED is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 397 product registrations across 352 distinct molecules. It is the 13th largest registrant in Pakistan by product count, and ranks 6th of 137 in Anti-Infectives. Its portfolio is concentrated in Anti-Infectives and Neuro. DRAP has issued 5 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by HILTON

463 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

216
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252
2026214

Top molecules by brand count

Metformin15 brands
Artemether11 brands
Levetiracetam11 brands
Amlodipine11 brands
Quetiapine10 brands
Lamotrigine8 brands
Fluoxetine6 brands
Ranitidine6 brands

Therapeutic classes

Anti-Infectives · 16Neuro · 14Blood Glucose Lowering Drugs, Excluding Insulin · 14Cardiac Care · 11Gastro · 10Diabetes · 8Antiepileptics · 7Pain Management · 7Antiinflammatory And Antirheumatic Products · 7Angiotensin-Ii Antagonists, Combinations · 7Other Beta-Lactam, Cephalosporins & Penems · 6Blood Conditions · 6

Conditions treated

General Infections · 9Oral Agents · 8Hypertension · 8Anxiety/Depression/Insomnia · 5Epilepsy/Convulsion · 5Malaria · 4Pain Killers · 4Colic/Constipation · 4Anaemia · 4Ulcer/Reflux/Flatulence/Acidity · 4Cold/Cough/Flu · 3High Cholestrol · 3

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official346 products · Rs 5.11 – Rs 366,618.96
DVAGO197 products · Rs 25.47 – Rs 4,324.4
Servaid200 products · Rs 50.01 – Rs 5,951
Median across source: Rs 402

Regulatory record

5 alerts in the DRAP feed we track.

RAPID ALERT – SPURIOUS/FALSIFIED (TABLET MYTEKA 10 mg)
2025-10-16
Rapid Alert: CRACKDOWN AGAINST FALSIFIED/SPURIOUS DRUGS
2025-05-22
Recall Alert: Voluntary Recall of all Batches of Lacolep Injection 10mg/ml Manufactured by
2025-02-25
Drug Product Recall: Cefim DS 200mg/5ml Suspension (Batch#141865) by M/S Hilton Pharma (Pv
2022-02-22
Drug Product Recall: Cefim 100mg/5ml Suspension (Batch#134774) , M/S Hilton Pharma (Pvt.)
2022-02-22

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 190 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
NABIQASIM INDUSTRIES (PVT) LTD. holds 131 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
Wilshire Laboratories (Private) Limited holds 78 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmoxicillinAmoxycillinAmoxycillin Base

Get the full profile for HILTON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.